Pfizer (FRA:PFEB) Short-Term Capital Lease Obligation: €0 Mil (As of Mar. 2026)


FRA:PFEB Pfizer Inc FRA:PFEB
74 GF Score
Price €6.80
GF Value €7.17
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer Short-Term Capital Lease Obligation?

Pfizer FRA:PFEB -2.16% 74 Short-Term Capital Lease Obligation is €0 Mil as of Mar. 2026. GuruFocus rates FRA:PFEB with a GF Score™ of 74/100 and a GF Value™ of €7.17 (Fairly Valued). The stock has 5 warning signs investors should review.

Pfizer's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2026 was €0 Mil.

Pfizer Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Pfizer Short-Term Capital Lease Obligation Related Terms

Pfizer Short-Term Capital Lease Obligation Historical Data

* Premium members only.

The historical data trend for Pfizer's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Short-Term Capital Lease Obligation Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:PFEB
74GF Score
Pfizer Inc FRA:PFEB
Short-Term Capital Lease Obligation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Short-Term Capital Lease Obligation of €0 Mil mean?
Pfizer (FRA:PFEB) has a Short-Term Capital Lease Obligation of €0 Mil as of Mar. 2026.
Is Pfizer's Short-Term Capital Lease Obligation too high?
Pfizer's current Short-Term Capital Lease Obligation is €0 Mil. Overall, Pfizer has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Short-Term Capital Lease Obligation compare to GILD and BMY?
Pfizer's Short-Term Capital Lease Obligation of €0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Capital Lease Obligation for a Drug Manufacturers company?
A good Short-Term Capital Lease Obligation depends on the Drug Manufacturers industry context. However, Short-Term Capital Lease Obligation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Capital Lease Obligation mean?
A high Short-Term Capital Lease Obligation can signal that a stock is expensive relative to its fundamentals. Pfizer's current Short-Term Capital Lease Obligation is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (FRA:PFEB) is currently considered Fairly Valued. The stock's GF Value™ is €7.17, compared to a current price of €6.80 — trading 5.2% below its estimated fair value. The current Short-Term Capital Lease Obligation is €0 Mil. Pfizer's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Capital Lease Obligation calculated?
Short-Term Capital Lease Obligation is calculated from a company's financial statements. For Pfizer (FRA:PFEB), the current Short-Term Capital Lease Obligation is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (FRA:PFEB) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of €6.80 is trading 5.2% below its estimated GF Value™ of €7.17. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for FRA:PFEB:

  • Short-Term Capital Lease Obligation: €0 Mil
  • GF Value™: €7.17 vs. price of €6.80 (5.2% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the FRA:PFEB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
74GF Score

Get the complete analysis for FRA:PFEB

Short-Term Capital Lease Obligation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.80
Price
€7.17
GF Value